Shire

News

Shire's von Willebrand disease therapy Veyvondi approved in ...

The European Commission has approved Shire’s Veyvondi for treatment of the bleeding disorder von Willebrand disease (VWD).

News

Shire buys Swiss plasma collection company sanaplasma

Shire has bought sanaplasma, a plasma collection company headquartered in Switzerland.

News

Bruce T. Martin Photography
508-655-7557
btm@brucetmartin.com
154 East Central St
Natick MA 01760

Shire eyes blockbuster sales as FDA approves HAE therapy

The FDA has approved Shire’s first antibody-based preventive treatment for the rare disease hereditary angioedema, raising hopes for blockbuster-level sales as the company prepares for a ta

News

Servier expands global footprint post Shire deal

Following its acquisition of Shire’s oncology business in April, Servier is taking steps to expand its presence in the US and China.

News

Roche haemophilia data piles pressure on Shire

Hemlibra threatens to take market share from Advate

News

Takeda to cut IT, marketing and sales jobs after Shire merge...

Takeda aiming for $1.4bn savings per year

Shire's von Willebrand disease therapy Veyvondi approved in ...

Shire buys Swiss plasma collection company sanaplasma

Shire eyes blockbuster sales as FDA approves HAE therapy

Servier expands global footprint post Shire deal

Roche haemophilia data piles pressure on Shire

Takeda to cut IT, marketing and sales jobs after Shire merge...

OpenBind unveils its first AI model for drug discovery

Discover a new era of healthcare panel engagement: Grounded ...

Shire

Editor's Picks